WUXI XDC (02268.HK) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Quote List Quote List

Event Tracking

Dec19

JPMorgan Sees Opportunities in China's Healthcare Sector, Recommends Biotech and CXO Stocks

02:54

Nov30

WuXi XTL Exercises Options to Issue 1.1133 Million Shares

23:44

Nov29

WuXi Biologics and Its Subsidiary Donate HKD 10 Million for Disaster Relief

07:20

Nov20

C.Sanchez 上调 WuXi Advanced Therapies 目标价 25% 至 90 元

01:12

Nov12

Jiangyin WuXi Advanced Facility Co., Ltd Established

07:13

Nov5

WuXi Advanced Therapies Maintains Strong Order Momentum, Annual Revenue Growth Target Met

07:38

Schedules & Filings

Schedules

Filings

Aug18

Earning Release(CST)

FY2025 Q2 Earning Release (HKD) Revenue 1.478 B, Net Income 408.09 M, EPS 0.3119

Mar24

Earning Release(CST)

FY2024 Q4 Earning Release (HKD) Revenue 1.27 B, Net Income 309.26 M, EPS 0.2392

Aug20

Earning Release(CST)

FY2024 Q2 Earning Release (HKD) Revenue 894.65 M, Net Income 262.31 M, EPS 0.2041

Stock List

Top Gainers

Top Decliners

Main Board

Symbol

Price

%Chg

Change